CUSIP 89532M101COMTRVIQ4 2025
55 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nea Management Company, LLC | 13.22M | $165.54M |
| 2 | Frazier Life Sciences Management, L.P. | 10.26M | $128.45M |
| 3 | Blackrock, Inc. | 10.13M | $126.78M |
| 4 | Fmr LLC | 6.50M | $81.38M |
| 5 | Vanguard Group Inc | 6.43M | $80.56M |
| 6 | Vivo Capital, LLC | 5.09M | $63.79M |
| 7 | Marshall Wace, LLP | 4.58M | $57.35M |
| 8 | Rubric Capital Management LP | 3.77M | $47.16M |
| 9 |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G | 5.0% | 6.43M | SEC |
| 5 | Nov 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 7.0% | 8.51M | SEC |
| 6 | Nov 14, 2025 | Viking Global Investors LP | 13G/A | 4.2% | 5.13M | SEC |
| 7 | Oct 17, 2025 | Blackrock, Inc. | 13G | 5.6% | 6.80M | SEC |
| 8 | Aug 14, 2025 | Viking Global Investors LP | 13G/A | 5.9% | 7.51M | SEC |
| 9 | Aug 11, 2025 | New Enterprise Associates 16, L.P. | 13D/A | 12.0% | — | SEC |
| 10 | Jul 9, 2025 | Rubric Capital Management LP | 13G | 7.1% | 8.53M | SEC |
See the full Schedule 13D/13G history for Trevi Therapeutics Inc.
Unlock full history| 3.40M |
| $42.62M |
| 10 | Mpm Bioimpact LLC | 3.29M | $41.15M |